Advertisement
PerkinElmer
PerkinElmer

Most Recent

image: Hearts on Trial

Hearts on Trial

By | May 1, 2015

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.

2 Comments

image: Viral Protector

Viral Protector

By | April 21, 2015

A retrovirus embedded in the human genome may help protect embryos from other viruses, and influence fetal development.

1 Comment

image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

0 Comments

image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By | April 17, 2015

A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.

1 Comment

image: Cancer Sequencing Controls

Cancer Sequencing Controls

By | April 15, 2015

Comparing a patient’s tumor DNA sequence with that of her normal tissue can improve researchers’ identification of disease-associated mutations.

1 Comment

image: Cannabidiol Quells Seizures

Cannabidiol Quells Seizures

By | April 14, 2015

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.

0 Comments

image: Why DBS Works for Parkinson’s?

Why DBS Works for Parkinson’s?

By | April 14, 2015

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.

0 Comments

image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

0 Comments

image: HIV Antibody Therapy

HIV Antibody Therapy

By | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.

0 Comments

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Brain on Fear
    The Scientist The Brain on Fear

    Scientists uncover the neurons in the mouse brain responsible for linking the sight of a looming object to scared behavior.

Advertisement
Bina Technologies
Bina Technologies
Advertisement
The Scientist